###begin article-title 0
###xml 137 141 <span type="species:ncbi:10090">Mice</span>
Cotransplantation of Cord Blood Hematopoietic Stem Cells and Culture-Expanded and GM-CSF-/SCF-Transfected Mesenchymal Stem Cells in SCID Mice
###end article-title 0
###begin p 1
###xml 563 564 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1047 1048 1043 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 915 920 <span type="species:ncbi:9606">human</span>
###xml 974 978 <span type="species:ncbi:10090">mice</span>
Mesenchymal stem cells (MSC) are multipotent in nature and believed to facilitate the engraftment of hematopoietic stem cells (HSC) when transplanted simultaneously in animal studies and even in human trials. In this study, we transfected culture-expanded MSC with granulocyte macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) cytokine genes and then cotransplanted with mononuclear cells (MNC) to further promote HSC engraftment. MNC were harvested from cord blood and seeded in long-term culture for ex vivo MSC expansion. A total of 1x107 MNC plus MSC/microL were introduced to the tail vein of nonobese diabetic/severe combined immunodeficiency mice. After 6-8 weeks later, homing and engraftment of human cells were determined by flow cytometry and fluorescence in situ hybridization studies. The total nucleated cell count and the engraftment of CD45+/CD34+ cells and XX or XY positive human cells were significantly increased in cotransplanted mice and even higher with the cytokine gene-transfected MSC (GM-CSF>SCF, p<0.05) than in transplantation of MNC alone. These results suggest that MSC transfected with hematopoietic growth factor genes are capable of enhancing the hematopoietic engraftment. Delivering genes involved in homing and cell adhesions, CXCR4 or VLA, would further increase the efficiency of stem cell transplantation in the future.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
The bone marrow stroma contains primitive and potentially self-renewing cells that can differentiate into various mesenchymal cells. These mesenchymal stem cells (MSC) are capable of supporting the expansion and differentiation of hematopoietic stem cells (HSC) in vitro and enhance hematopoietic engraftment in vivo (1-5). Furthermore, MSC express class I, but not class II, histocompatibility antigens, and they are not immunogenic in in vitro assays and in preclinical or clinical models.
###end p 3
###begin p 4
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 212 221 <span type="species:ncbi:10090">nude mice</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
Recently, it has been reported that there are mesenchymal precursors in cord blood and peripheral blood of normal individuals. The results obtained demonstrate that after systemic infusion of cord blood MSC into nude mice, human DNA was found in the marrow and in ex vivo expanded stromal cells grown from the marrow of transplanted animals. Several groups also have reported bone and fat differentiation capacity from cord blood-derived nonhematopoietic cells (6-10). Despite the low initial frequency in cord blood, MSC have a tremendous expansion potential in culture. Due to the limited number of HSC in a given cord blood unit, the outcome of HSC transplantation (HSCT) could be improved by coengraftment of the MSC in addition to the hematopoietic precursors.
###end p 4
###begin p 5
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 946 951 <span type="species:ncbi:9606">human</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
Several lines of evidence suggest that MSC produce some essential hematopoietic growth factors (1-5). Based on these reports, we hypothesized that exogenously administered MSC with cytokine gene-transfected would show additive or augmented effects on HSC expansion. In this study, mononuclear cells (MNC) were harvested from cord blood and seeded in long-term culture for ex vivo MSC expansion. We transfected culture-expanded MSC with granulocyte macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) cytokine genes and then cotransplanted with cord blood MNC in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice to further promote HSC engraftment. Although CD34+ cells can be selected for the preparation of HSC, many cord blood HSCT practically use unselected MNC. Therefore, we chose unselected MNC samples instead of selected samples as the source of stem cells for transplantation. Our results show that human cells were significantly increased in cotransplanted mice, and the number was even higher with the cytokine gene-transfected MSC than with transplantation of MNC alone. These data not only provide direct evidence for the presence of MSC in cord blood, but could also add to therapeutic profile of expanded MSC for clinical use.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Ex vivo MSC culture
###end title 7
###begin p 8
###xml 228 229 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cord blood samples were collected from the umbilical vein after full-term vaginal delivery. Informed consent was obtained from all mothers. The mononuclear cell fractions from cord blood were suspended at a concentration of 1x106 cells/mL in MesenCult medium (StemCell Technologies, Inc., Vancouver, BC, Canada) and seeded in T-25 flasks. Cultures were maintained at 37â„ƒ in humidified air and 5% CO2 with a regular change of medium. After removal of non-adherent cells, the adherent layer was further cultured until 80-90% confluence. At this point, the cell population was expanded by successive passage and resulting adherent cells were used for experiments.
###end p 8
###begin p 9
###xml 315 321 <span type="species:ncbi:9913">bovine</span>
The adherent cells were detached with 0.05% trypsin-ethylenediamine tetraacetic acid and washed with phosphate-buffered saline (PBS). We observed morphology of detached cells after Wright-Giemsa staining. The phenotype and purity of MSC were assessed by flow cytometry. The cells were washed with PBS containing 2% bovine serum albumin, and incubated with FITC-conjugated CD45 (BD Biosciences, San Jose, CA, U.S.A.), PE-conjugated CD73 (BD Biosciences), CD105 (DiNonA, Inc., Seoul, Korea), and CD166 (BD Biosciences) on ice for 30 min in the dark. Those 3 monoclonal antibodies were chosen because of the popularity and accessibility. After fixation with 1% paraformaldehyde, flow cytometry was performed on the FACSort instrument (Becton Dickinson, San Jose, CA, U.S.A.).
###end p 9
###begin title 10
GM-CSF/SCF gene transfection
###end title 10
###begin p 11
###xml 314 319 <span type="species:ncbi:9606">human</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
For plasmid transfections, pEGFP-N1 DNA (Clontech, Palo Alto, CA, U.S.A.) that encodes an enhanced green fluorescent protein (EGFP) was used. Expanded MSC were transfected with an EGFP-expressing vectors after cloning with GM-CSF (pEGFP-N1/GM-CSF) or SCF (pEGFP-N1/SCF). To create pEGFP-N1/GM-CSF or pEGFP-N1/SCF, human peripheral blood monocytes were used for reverse transcription-polymerase chain reaction. After sequencing of GM-CSF and SCF genes, EcoRI was used for digestion to insert cDNA3.1 and NotI was treated for SCF. Stable MSC transfectants that expressed high levels of GFP were cloned by limiting dilution and selected using 2 mg/mL neomycin (Invitrogen Corp., Carlsbad, CA, U.S.A.). The GFP-expressing cells were screened by a microplate spectrofluorometer (Shimadzu, Kyoto, Japan) and confirmed by an enzyme-linked immunosorbent assay (ELISA) (R & D Systems, Minneapolis, MN, U.S.A.). Stable clones of MSC with GFP and GM-CSF or SCF were maintained in Dulbecco Modified Eagle Medium (Gibco Laboratories, Grand Island, NY, U.S.A.) in the presence of neomycin until transplantation. GFP-positive MSC were visualized using a fluorescence microscope (Olympus, Japan) and then used for transplantation to NOD/SCID mice.
###end p 11
###begin title 12
Transplantation and analysis of engraftment
###end title 12
###begin p 13
###xml 422 423 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 531 532 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 610 611 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 690 691 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 710 715 <span type="species:ncbi:10090">mouse</span>
NOD/SCID mice were purchased from Korea Research Institute of Bioscience and Biotechnology (KRIBB, Daejeon, Korea) and were maintained in sterile microisolator cages. All mice received sublethal total body irradiation with a single dose of 250 cGy. Twelve to 24 hr after irradiation, cells in a final volume of 200 microL were injected through the tail vein. We designed 4 experimental groups, and each group received 1x107 cells as a total: group 1 (n=5) received MNC only, group 2 (n=7) received a mixture of MNC plus MSC, 0.5x107 respectively, group 3 (n=7) received a mixture of MNC plus GM-CSF MSC, 0.5x107 respectively, and group 4 (n=6) received a mixture of MNC plus SCF MSC, 0.5x107 respectively, per mouse. MNC were isolated from cord blood using a density gradient centrifugation. All cells were used fresh without cryopreservation.
###end p 13
###begin p 14
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 220 225 <span type="species:ncbi:9606">Human</span>
###xml 763 768 <span type="species:ncbi:9606">human</span>
Six to 8 weeks later, blood samples were collected from the retroorbital venous plexus of the NOD/SCID mice. An aliquot of the blood was used for complete blood cell counts by Sysmex XE-2100 (Sysmex Corp., Kobe, Japan). Human cell engraftment was detected by flow cytometry, using FITC-conjugated CD45 (BD Biosciences) and PE-conjugated CD34 (BD Biosciences) antibodies. Positive cells were identified by comparison with isotype controls. A part of venous blood was also exposed to a hypotonic solution, and fixed in methanol/acetic acid fixative. Nuclei were then stained with CEP X (DXZ1) alpha satellite probe (Vysis, Inc., Downers Grove, IL, U.S.A.) and CEP Y (DYZ1) satellite III probe (Vysis) for fluorescence in situ hybridization (FISH) identification of human cells. A total of at least 500-700 nuclei were examined in each case under a fluorescent microscope.
###end p 14
###begin p 15
###xml 163 164 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The results were expressed as mean+/-standard deviation. Differences in engraftment percentages between experimental conditions were analyzed by Student-t test. A p value less than 0.05 was considered statistically significant.
###end p 15
###begin title 16
RESULTS
###end title 16
###begin p 17
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 418 425 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 549 555 549 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
Adherent MSC could be expanded from all of the cord blood analyzed. Primary cultures of MSC mainly consisted of colonies of spindle-shaped fibroblastoid cells (Fig. 1A). Confluence was usually reached after 2-3 weeks. Wright-Giemsa staining of detached MSC showed a large cell population characterized by abundant cytoplasms with occasional vacuoles and projections, fine nuclear chromatins, and one or more nucleoli (Fig. 1B). Flow cytometry analyses demonstrated that MSC expressed CD73, CD105, and CD166 in all cases, but were negative for CD45 (Fig. 2). The purity of expanded MSC was 85-97%.
###end p 17
###begin p 18
###xml 320 326 320 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 595 596 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 741 742 733 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
At 24 hr after transfection, increased GFP expression was identified both by spectrofluorometry and ELISA. The transfected MSC showed visible GFP expression as early as 3 hr after transfection. The highest efficiency of the transfection was obtained after 5-7 days of culture both with pEGFP-N1/GM-CSF and pEGFP-N1/SCF (Fig. 3, 4). On average 50-70% of transfected MSC expressed GFP. Detached MSC were then ready for transplantation. ELISA detected increased GM-CSF levels from MSC cultures after transfection (273.78+/-148.33 pg/mL) compared to those before transfection (34.35+/-17.06 pg/mL) (p<0.05, n=4). SCF also increased from 1.30+/-1.05 pg/mL to 24.10+/-20.21 pg/mL post transfection, however, there were no statistical differences (p>0.05, n=4).
###end p 18
###begin p 19
###xml 107 108 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 153 154 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 209 216 197 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 274 280 262 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 345 346 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 375 376 355 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 386 387 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 505 506 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 576 577 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 614 615 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 719 720 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 772 773 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 858 859 810 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 979 986 931 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 988 994 940 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
In MNC transplantation alone, the absolute numbers of total nucleated cell (TNC) count was 0.08+/-0.04 (x103/microL) (n=5) comparable to 0.13+/-0.05 (x103/microL) (n=7) in mice transplanted with MNC plus MSC (Table 1). However, higher levels of human XX or XY cell by FISH (Fig. 5) were found in transplantation of MNC plus MSC, 0.41+/-0.41 (x103/microL) vs. 1.52+/-0.81 (x103/microL) (p<0.05). Cotransplantation of MNC and GM-CSF-transfected MSC most enhanced engraftment. The TNC count, 4.63+/-0.96 (x103/microL) (n=7), and the percentage of XX or XY cells, 5.68+/-0.58 (x103/microL), were significantly higher (p<0.05) than those after transplantation of MNC alone. Also, higher levels of TNC count, 2.93+/-0.33 (x103/microL) (n=6), and XX or XY cells, 3.43+/-0.49 (x103/microL), were obtained following cotransplantation of MNC plus SCF-transfected MSC (p<0.05). Engraftment study with immunophenotypic analysis of CD45+/CD34+ cells by flow cytometry showed similar results (Table 1, Fig. 6).
###end p 19
###begin title 20
DISCUSSION
###end title 20
###begin p 21
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 813 815 813 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 800 805 <span type="species:ncbi:9606">human</span>
Genetic modification of stem cells is an attractive target for gene therapy because of their higher proliferative capacity and long-term survival compared with other somatic cells. MSC have been demonstrated to be able to express exogenous protein for an extended period of time and to maintain this ability after transplantation in vitro (1, 11-14). Gene modified MSC are useful as therapeutic tools for various tumors. MSC with forced expression of interferon beta were shown to inhibit the growth of malignant cells in vivo (11, 12). Gene-modification of MSC with therapeutic cytokines also clearly augmented the antitumor effect and prolonged the survival of tumor-bearing animals (13). Recently more efficient non-viral DNA transfection methods have been introduced to obtain stably transfected human cells (14, 15).
###end p 21
###begin p 22
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 232 237 <span type="species:ncbi:9606">Human</span>
Ex vivo expanded MSC have been infused in several transplantation studies. It is possible that a therapeutic benefit from MSC could be obtained by local production of growth factors and the provision of temporary immunosuppression. Human MSC have a high expansion potential, genetic stability, and reproducible characteristics proven in widely dispersed laboratories (1-3). No adverse events during or after MSC infusion have been reported, and no ectopic tissue formation has been observed.
###end p 22
###begin p 23
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 848 856 <span type="species:ncbi:9606">patients</span>
###xml 1008 1012 <span type="species:ncbi:10090">mice</span>
###xml 1070 1075 <span type="species:ncbi:9606">human</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
Based on these results, we hypothesized that exogenously administered MSC with cytokine gene-transfected would show additive or augmented effects on HSC expansion. Among the various cytokines, we have previously demonstrated that the combination of SCF, thrombopoietin, and flt3 ligand is sufficient for ex vivo expansion of cord blood (16). With the addition of granulocyte (G)-CSF, the clonogenic and homing potentials of cord blood were even higher, although statistically significant differences were not observed. Ramirez et al. (17) also have shown that SCF, interleukin (IL)-3, IL-6, and GM-CSF could induce the up-regulation of several adhesion molecules involved in the mobilization and homing of HSC. Currently GM-CSF is one of the most widely used cytokines for the purpose of stem cell mobilization and for the treatment of neutropenic patients. Therefore, we transfected culture-expanded cord blood MSC with GM-CSF and SCF cytokine genes, and then cotransplanted with cord blood MNC in NOD/SCID mice to further promote HSC engraftment. We demonstrated that human cells were significantly increased in cotransplanted mice and even higher with the cytokine gene-transfected MSC than in transplantation of MNC alone. Cotransplantation of MNC and GM-CSF-transfected MSC most enhanced engraftment.
###end p 23
###begin p 24
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 973 974 973 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 975 976 975 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1167 1169 1167 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 57 63 <span type="species:ncbi:9606">humans</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
Cotransplantation studies in animal models as well as in humans showed that primary or culture-expanded MSC promote the engraftment of HSC (18-22). Cotransplantation of MSC and cord blood (18, 19, 21) or mobilized peripheral blood (20) CD34+ cells resulted in a significantly higher level of engraftment than with transplantation of CD34+ cells only. Cotransplantation of human leukocyte antigen (HLA)-identical sibling culture-expanded MSC with an HLA-identical sibling HSC was also feasible and safe without immediate infusional or late MSC-associated toxicities (22). The mechanism of the enhancing effect is still unknown. Several lines of evidence suggest that MSC produce several essential hematopoietic growth factors including IL-6, IL-11, SCF, leukemia inhibitory factor, and flt3 ligand and express adhesion molecules and extracellular matrix proteins that are known to play an important role in HSC homing such as VCAM1, E-selectin, collagen I, and fibronectin (1-5, 20, 23). Different studies report that MSC have an immunomodulatory effect and are able to suppress proliferation of T lymphocytes both by cell-cell interaction and via soluble factors (22-25).
###end p 24
###begin p 25
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
It has been claimed that there are mesenchymal precursors in cord blood and peripheral blood of normal individuals (6-8, 26, 27). Despite the low initial frequency in cord blood, MSC have a tremendous expansion potential in culture. Compared to bone marrow MSC, cord blood cultures were slower to establish, but once established, the growth was maintained over multiple passages. Using optimized isolation and culture conditions, cells showing a characteristic mesenchymal morphology and immune phenotype were isolated. The frequency of MSC ranged from 0-2.3 clones per 1x108 MNC. Due to the limited number of HSC in a given cord blood unit, the outcome of HSC transplantation could be improved by coengraftment of the MSC in addition to the hematopoietic precursors.
###end p 25
###begin p 26
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 125 134 <span type="species:ncbi:10090">nude mice</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 608 613 <span type="species:ncbi:9606">human</span>
Erices et al. (8) previously investigated the capability of transplanted cord blood MSC to home and survive in the marrow of nude mice. They have detected human DNA after transplantation in the marrow of recipients as well as in ex vivo-expanded stromal cells prepared from the marrow of transplants. In this study we found that cord blood MSC cotransplantation enhances human cell engraftment. This enhancement was greater after cotransplantation of GM-CSF- and SCF-transfected MSC. According to Wagner et al. (26) several genes involved in mesodermal differentiation were differently expressed on MSC from human bone marrow, adipose tissue, or umbilical cord blood. These results implied that potentials of mesodermal development might be different depending on MSC preparations. By upregulating genes involved in proliferation and homing of cord blood MSC, this might contribute to establish a reliable genetic modification system for clinical applications.
###end p 26
###begin p 27
###xml 544 545 544 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
MSC are multipotent and believed to facilitate the engraftment of HSC when transplanted simultaneously in animal studies, and recently, even in human trials. In this study, we transfected culture-expanded cord blood MSC with GM-CSF and SCF cytokine genes and then cotransplanted with cord blood HSC to further promote HSC engraftment. The TNC count and the engraftment of CD45+/CD34+ cells and XX or XY positive human cells were significantly increased in cotransplanted mice and even higher with the cytokine gene-transfected MSC (GM-CSF>SCF, p<0.05) than in transplantation of HSC alone. Our results indicate that MSC may serve as a platform to deliver hematopoietic growth factors in clinical stem cell transplantation. Delivering genes involved in homing and cell adhesions, CXCR4 or VLA, would further increase the efficiency of stem cell transplantation in the future.
###end p 27
###begin p 28
###xml 72 119 72 119 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ministry of Health &amp; Welfare, Republic of Korea</funding-source>
###xml 121 142 121 142 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">03-PJ1-PG3-20500-0065</award-id>
This study was supported by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (03-PJ1-PG3-20500-0065).
###end p 28
###begin article-title 29
Mesenchymal stem cells: biological characteristics and potential clinical applications
###end article-title 29
###begin article-title 30
Mesenchymal stem cells: progress toward promise
###end article-title 30
###begin article-title 31
Integral therapeutic potential of bone marrow mesenchymal stem cells
###end article-title 31
###begin article-title 32
Pluripotency of mesenchymal stem cells derived from adult marrow
###end article-title 32
###begin article-title 33
Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells
###end article-title 33
###begin article-title 34
###xml 32 37 <span type="species:ncbi:9606">human</span>
Mesenchymal progenitor cells in human umbilical cord blood
###end article-title 34
###begin article-title 35
Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers
###end article-title 35
###begin article-title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Human cord blood-derived mesenchymal stem cells home and survive in the marrow of immunodeficient mice after systemic infusion
###end article-title 36
###begin article-title 37
Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics
###end article-title 37
###begin article-title 38
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation
###end article-title 38
###begin article-title 39
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors
###end article-title 39
###begin article-title 40
Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
###end article-title 40
###begin article-title 41
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy
###end article-title 41
###begin article-title 42
###xml 33 38 <span type="species:ncbi:9606">human</span>
Highly efficient transfection of human marrow stromal cells by nucleofection
###end article-title 42
###begin article-title 43
###xml 63 68 <span type="species:ncbi:9606">human</span>
Nucleofection as an efficient nonviral transfection method for human monocytic cells
###end article-title 43
###begin article-title 44
Stem cells expressing homing receptors could be expanded from cryopreserved and unselected cord blood
###end article-title 44
###begin article-title 45
Ex vivo expansion of umbilical cord blood (UCB) CD34+ cells alters the expression and function of alpha 4 beta 1 and alpha 5 beta 1 integrins
###end article-title 45
###begin article-title 46
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice
###end article-title 46
###begin article-title 47
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34+ cells in NOD/SCID mice
###end article-title 47
###begin article-title 48
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice
###end article-title 48
###begin article-title 49
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment
###end article-title 49
###begin article-title 50
###xml 138 146 <span type="species:ncbi:9606">patients</span>
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
###end article-title 50
###begin article-title 51
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward Stromal and osteogenic lineages
###end article-title 51
###begin article-title 52
###xml 134 140 <span type="species:ncbi:10090">murine</span>
Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation
###end article-title 52
###begin article-title 53
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation
###end article-title 53
###begin article-title 54
###xml 59 64 <span type="species:ncbi:9606">human</span>
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood
###end article-title 54
###begin article-title 55
Clinical parameters for the isolation of mesenchymal stem cells from umbilical cord blood
###end article-title 55
###begin p 56
###xml 94 95 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 155 156 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Inverted phase contrast microscopic findings of cultured cord blood MSC at passage 2, day 14 (A) (x150). Wright-Giemsa stained smear of the harvested MSC (B) (x1,000).
###end p 56
###begin p 57
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
Representative immunophenotypic analysis of MSC ex vivo cultures from the cord blood. CD45-/CD73+ (95.7%), CD45-/CD 105+ (97.4%), and CD45-/CD166+ cells (94.9%) were evident by flow cytometry.
###end p 57
###begin p 58
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 155 156 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 188 189 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
GM-CSF transfection studies. Microscopic images of phase contrast (A) and fluorescence microscopes (B) before transfection. Micrographs of phase contrast (C) and fluorescence microscopes (D) post transfection day 5. The panel D shows GFP fluorescence, indicating GFP-expressing MSC after transfection (x200).
###end p 58
###begin p 59
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 97 98 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 152 153 152 153 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 185 186 185 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
SCF transfection studies. Microscopic images of phase contrast (A) and fluorescence microscopes (B) before transfection. Micrographs of phase contrast (C) and fluorescence microscopes (D) post transfection day 7. The panel D shows GFP fluorescence, indicating GFP-expressing MSC after transfection (x200).
###end p 59
###begin p 60
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
XY human cells identified from the peripheral blood of NOD/SCID mice 7 weeks after cotransplantation of GM-CSF-transfected cord blood MSC and MNC (x1,000). One orange signal indicates one copy of the X chromosome, and one green signal indicates one copy of the Y chromosome.
###end p 60
###begin p 61
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Representative CD34+/CD45+ cells (8.7%) detected from venous blood of NOD/SCID mice 7 weeks after cotransplantation of GM-CSF-transfected cord blood MNC and HSC.
###end p 61
###begin p 62
Comparison between HSC transplantation alone and cotransplantation of MNC plus MSC alone or MNC plus GM-CSF-/SCF-transfected MSC
###end p 62
###begin p 63
MNC, mononuclear cells; MSC, mesenchymal stem cells; GM-CSF, granulocyte macrophage-colony stimulating factor; SCF, stem cell factor; TNC, total nucleated cells.
###end p 63

